CD4 and neoplasm: Our study found that high-risk patients have lower infiltration of anti-tumor immune cells (memory B cells, plasma cells, CD4+ T cells, NK cells, DCs), while exhibiting higher levels of M2-type TAMs that promote tumor growth and immunosuppression.